177 related articles for article (PubMed ID: 2767221)
1. Mechanisms of macrolide resistance in Ureaplasma urealyticum: a study on collection and clinical strains.
Palù G; Valisena S; Barile MF; Meloni GA
Eur J Epidemiol; 1989 Jun; 5(2):146-53. PubMed ID: 2767221
[TBL] [Abstract][Full Text] [Related]
2. The in vitro activity of some 14-, 15- and 16- membered macrolides against Staphylococcus spp., Legionella spp., Mycoplasma spp. and Ureaplasma urealyticum.
Felmingham D; Robbins MJ; Sanghrajka M; Leakey A; Ridgway GL
Drugs Exp Clin Res; 1991; 17(2):91-9. PubMed ID: 1650694
[TBL] [Abstract][Full Text] [Related]
3. In vitro activity of antibiotics against Ureaplasma urealyticum and Chlamydia trachomatis strains from patients with nongonococcal urethritis.
Busolo F; Conventi L
Eur J Clin Microbiol Infect Dis; 1988 Jun; 7(3):407-10. PubMed ID: 3137045
[TBL] [Abstract][Full Text] [Related]
4. Standardized method for determining antimicrobial susceptibility of strains of Ureaplasma urealyticum and their response to tetracycline, erythromycin, and rosaramicin.
Robertson JA; Coppola JE; Heisler OR
Antimicrob Agents Chemother; 1981 Jul; 20(1):53-8. PubMed ID: 7283415
[TBL] [Abstract][Full Text] [Related]
5. In vitro susceptibility of Ureaplasma urealyticum clinical isolates to new macrolides.
Kanamoto Y; Miyake Y; Suginaka H; Usui T
Chemotherapy; 1991; 37(4):256-9. PubMed ID: 1790724
[TBL] [Abstract][Full Text] [Related]
6. In vitro susceptibilities of mycoplasmas and ureaplasmas to new macrolides and aryl-fluoroquinolones.
Waites KB; Cassell GH; Canupp KC; Fernandes PB
Antimicrob Agents Chemother; 1988 Oct; 32(10):1500-2. PubMed ID: 2973283
[TBL] [Abstract][Full Text] [Related]
7. In vitro activity of azithromycin against Chlamydia trachomatis, Ureaplasma urealyticum and Mycoplasma hominis in comparison with erythromycin, roxithromycin and minocycline.
Rumpianesi F; Morandotti G; Sperning R; Satta G; Cevenini R
J Chemother; 1993 Jun; 5(3):155-8. PubMed ID: 8396626
[TBL] [Abstract][Full Text] [Related]
8. Tetracycline-resistant Ureaplasma urealyticum: a cause of persistent nongonococcal urethritis.
Stimson JB; Hale J; Bowie WR; Holmes KK
Ann Intern Med; 1981 Feb; 94(2):192-4. PubMed ID: 7469210
[TBL] [Abstract][Full Text] [Related]
9. Resistance of Mycoplasma pneumoniae to macrolide and analogous antibiotics.
Suzaki K
Sci Rep Res Inst Tohoku Univ Med; 1979 Dec; 26(3-4):71-91. PubMed ID: 121168
[TBL] [Abstract][Full Text] [Related]
10. [Biological properties of Ureaplasma urealyticum and Mycoplasma hominis isolated from patients with urethritis. V. Sensitivity of U. urealyticum to selected chemotherapeutic agents].
Jagielski M
Med Dosw Mikrobiol; 1988; 40(1):18-37. PubMed ID: 3210836
[No Abstract] [Full Text] [Related]
11. Ureaplasma urealyticum: subcultures invalid for antibiotic susceptibility tests.
Kundsin RB; Poulin SA
Diagn Microbiol Infect Dis; 1985 Jul; 3(4):329-36. PubMed ID: 4028663
[TBL] [Abstract][Full Text] [Related]
12. Anti-mycoplasmal activity of a new macrolide: miocamycin.
Furneri PM; Tempera G; Bisignano G; Cottarelli FV; Nicoletti G
Chemioterapia; 1987 Oct; 6(5):341-5. PubMed ID: 3501335
[TBL] [Abstract][Full Text] [Related]
13. Persistent nongonococcal urethritis associated with a minocycline-resistant strain of Ureaplasma urealyticum: a case report.
Magalhães M
Sex Transm Dis; 1983; 10(3):151-2. PubMed ID: 6648750
[TBL] [Abstract][Full Text] [Related]
14. [Frequency and antibiotic resistance of Ureaplasma urealyticum and Mycoplasma hominis in genital samples of sexually active individuals].
Farkas B; Ostorházi E; Pónyai K; Tóth B; Adlan E; Párducz L; Marschalkó M; Kárpáti S; Rozgonyi F
Orv Hetil; 2011 Oct; 152(42):1698-702. PubMed ID: 21979223
[TBL] [Abstract][Full Text] [Related]
15. Antibacterial Resistance in Ureaplasma Species and Mycoplasma hominis Isolates from Urine Cultures in College-Aged Females.
Valentine-King MA; Brown MB
Antimicrob Agents Chemother; 2017 Oct; 61(10):. PubMed ID: 28827422
[TBL] [Abstract][Full Text] [Related]
16. Antimicrobial activity of Manuka honey against antibiotic-resistant strains of the cell wall-free bacteria Ureaplasma parvum and Ureaplasma urealyticum.
Hillitt KL; Jenkins RE; Spiller OB; Beeton ML
Lett Appl Microbiol; 2017 Mar; 64(3):198-202. PubMed ID: 27992658
[TBL] [Abstract][Full Text] [Related]
17. Rosamicin, a macrolide with in vitro activity against Ureaplasma urealyticum.
Hill AC; Sutton G
J Antibiot (Tokyo); 1979 Sep; 32(9):915-9. PubMed ID: 511782
[TBL] [Abstract][Full Text] [Related]
18. Clinical antibiotic resistance of Ureaplasma urealyticum.
Taylor-Robinson D; Furr PM
Pediatr Infect Dis; 1986; 5(6 Suppl):S335-7. PubMed ID: 3540906
[TBL] [Abstract][Full Text] [Related]
19. Antibiotic susceptibilities and resistance genes of Ureaplasma parvum isolated in South Africa.
Govender S; Gqunta K; le Roux M; de Villiers B; Chalkley LJ
J Antimicrob Chemother; 2012 Dec; 67(12):2821-4. PubMed ID: 22879459
[TBL] [Abstract][Full Text] [Related]
20. In vitro comparison of the activity of doxycycline, tetracycline, erythromycin and a new macrolide, CP 62993, against Mycoplasma pneumoniae, Mycoplasma hominis and Ureaplasma urealyticum.
Rylander M; Hallander HO
Scand J Infect Dis Suppl; 1988; 53():12-7. PubMed ID: 2843982
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
